Facing challenges when purifying non-traditional mAbs?
Sept. 24, 2025
Sponsored by
As monoclonal antibody (mAb) modalities become increasingly complex, traditional purification methods often fall short. This article provides invaluable insights from three in-house specialists at Thermo Fisher Scientific, addressing the unique challenges faced in the purification of complex mAbs.
Key Takeaways:
Learn how to optimize purification strategies for non-traditional mAbs with the help of affinity chromatography technology
Discover new approaches to tackle impurities introduced by novel mAb structures.
Learn how you can refine your polishing processes to achieve maximum efficiency.
Equip yourself with the knowledge to navigate the complexities of mAb purification and elevate your process development strategies.